Symbols / PRPH $0.08 -11.11% ProPhase Labs, Inc.

Healthcare • Diagnostics & Research • United States • PNK
PRPH Chart
About

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides a broad range of COVID-19 related clinical diagnostic and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as well as rapid antigen testing for COVID-19. It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Diagnostics & Research Market Cap 378.96K
Enterprise Value 7.69M Income -49.56M Sales 5.05M
Book/sh 1.65 Cash/sh 0.09 Dividend Yield —
Payout 0.00% Employees 96 IPO —
P/E — Forward P/E 0.17 PEG —
P/S 0.07 P/B 0.05 P/C —
EV/EBITDA -0.32 EV/Sales 1.52 Quick Ratio 0.07
Current Ratio 0.14 Debt/Eq 112.00 LT Debt/Eq —
EPS (ttm) -19.80 EPS next Y 0.48 EPS Growth —
Revenue Growth -37.60% Earnings 2026-04-14 ROA -23.50%
ROE -220.34% ROIC — Gross Margin 19.52%
Oper. Margin -5.40% Profit Margin 0.00% Shs Outstand 4.74M
Shs Float 4.32M Short Float 0.71% Short Ratio 0.08
Short Interest — 52W High 6.70 52W Low 0.07
Beta -0.32 Avg Volume 265.70K Volume 1.16K
Target Price — Recom None Prev Close $0.09
Price $0.08 Change -11.11%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.09
Latest analyst target
3. DCF / Fair value
$193.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.09
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-02-21 reit HC Wainwright & Co. Buy → Buy $11
2023-11-10 main HC Wainwright & Co. Buy → Buy $11
2023-08-14 reit HC Wainwright & Co. Buy → Buy $14
2023-06-02 reit HC Wainwright & Co. Buy → Buy $14
2023-05-12 main HC Wainwright & Co. Buy → Buy $14
2023-03-08 reit HC Wainwright & Co. — → Buy $15
2023-02-23 reit HC Wainwright & Co. — → Buy $15
2023-02-16 reit HC Wainwright & Co. — → Buy $15
2023-02-07 reit HC Wainwright & Co. — → Buy $15
2022-11-11 main HC Wainwright & Co. — → Buy $15
2022-05-17 main HC Wainwright & Co. — → Buy $14
2022-03-31 main HC Wainwright & Co. — → Buy $16
2022-01-14 main HC Wainwright & Co. — → Buy $15
2021-12-20 init HC Wainwright & Co. — → Buy $12
2021-10-13 down Dawson James Buy → Neutral —
News
RSS: Latest PRPH news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
6.77
-80.65%
34.98
-71.48%
122.65
+55.17%
79.04
Operating Revenue
6.77
-80.65%
34.98
-71.48%
122.65
+55.17%
79.04
Cost Of Revenue
6.92
-64.38%
19.43
-62.63%
51.99
+40.32%
37.05
Reconciled Cost Of Revenue
6.92
-64.38%
19.43
-62.63%
51.99
+40.32%
37.05
Gross Profit
-0.15
-100.96%
15.56
-77.98%
70.65
+68.27%
41.99
Operating Expense
38.48
+4.63%
36.78
-21.85%
47.06
+46.20%
32.19
Research And Development
0.59
-57.63%
1.40
+115.03%
0.65
+25.38%
0.52
Selling General And Administration
37.88
+13.29%
33.44
-2.74%
34.38
+52.87%
22.49
General And Administrative Expense
37.88
+13.29%
33.44
-2.74%
34.38
+52.87%
22.49
Other Gand A
37.88
+13.29%
33.44
-2.74%
34.38
+52.87%
22.49
Other Operating Expenses
—
1.93
-83.93%
12.02
+31.04%
9.17
Total Expenses
45.40
-19.22%
56.20
-43.26%
99.05
+43.05%
69.24
Operating Income
-38.63
-82.04%
-21.22
-189.93%
23.59
+140.74%
9.80
Total Operating Income As Reported
-38.63
-82.04%
-21.22
-189.93%
23.59
+140.74%
9.80
EBITDA
-32.34
-120.56%
-14.66
-151.02%
28.73
+186.87%
10.02
Normalized EBITDA
-32.00
-118.29%
-14.66
-150.89%
28.81
+105.69%
14.01
Reconciled Depreciation
6.64
+2.67%
6.47
+27.86%
5.06
+42.04%
3.56
EBIT
-38.98
-84.46%
-21.13
-189.27%
23.67
+266.84%
6.45
Total Unusual Items
-0.33
0.00
+100.00%
-0.08
+98.10%
-3.99
Total Unusual Items Excluding Goodwill
-0.33
0.00
+100.00%
-0.08
+98.10%
-3.99
Special Income Charges
-0.33
0.00
0.00
+100.00%
-3.75
Other Special Charges
0.33
—
—
—
Write Off
—
—
0.00
-100.00%
3.75
Net Income
-53.36
-217.98%
-16.78
-190.90%
18.46
+194.32%
6.27
Pretax Income
-42.33
-88.99%
-22.40
-197.77%
22.91
+331.82%
5.30
Net Non Operating Interest Income Expense
-3.35
-181.99%
-1.19
-94.44%
-0.61
-20.75%
-0.51
Interest Expense Non Operating
3.35
+164.61%
1.27
+65.71%
0.76
-33.45%
1.15
Net Interest Income
-3.35
-181.99%
-1.19
-94.44%
-0.61
-20.75%
-0.51
Interest Expense
3.35
+164.61%
1.27
+65.71%
0.76
-33.45%
1.15
Interest Income Non Operating
0.00
-100.00%
0.08
-49.02%
0.15
-76.17%
0.64
Interest Income
0.00
-100.00%
0.08
-49.02%
0.15
-76.17%
0.64
Other Income Expense
-0.35
-3610.00%
0.01
+113.16%
-0.08
+98.10%
-3.99
Other Non Operating Income Expenses
-0.02
-280.00%
0.01
—
—
Gain On Sale Of Security
—
—
-0.08
+68.33%
-0.24
Tax Provision
7.20
+219.56%
-6.02
-235.39%
4.45
+559.19%
-0.97
Tax Rate For Calcs
0.00
-21.84%
0.00
+38.47%
0.00
-28.13%
0.00
Tax Effect Of Unusual Items
-0.07
0.00
+100.00%
-0.01
+98.63%
-1.08
Net Income Including Noncontrolling Interests
-53.36
-217.98%
-16.78
-190.90%
18.46
+194.32%
6.27
Net Income From Continuing Operation Net Minority Interest
-49.52
-202.35%
-16.38
-188.72%
18.46
+194.32%
6.27
Net Income From Continuing And Discontinued Operation
-53.36
-217.98%
-16.78
-190.90%
18.46
+194.32%
6.27
Net Income Continuous Operations
-49.52
-202.35%
-16.38
-188.72%
18.46
+194.32%
6.27
Net Income Discontinuous Operations
-3.84
-854.98%
-0.40
—
0.00
Normalized Income
-49.26
-200.74%
-16.38
-188.42%
18.52
+101.66%
9.19
Net Income Common Stockholders
-53.36
-217.98%
-16.78
-190.90%
18.46
+194.32%
6.27
Diluted EPS
-26.10
-166.33%
-9.80
-196.08%
10.20
+155.00%
4.00
Basic EPS
-26.10
-166.33%
-9.80
-183.76%
11.70
+185.37%
4.10
Basic Average Shares
2.99
+73.62%
1.72
+8.60%
1.58
+4.44%
1.52
Diluted Average Shares
2.99
+73.62%
1.72
-7.74%
1.87
+1.40%
1.84
Diluted NI Availto Com Stockholders
-53.36
-217.98%
-16.78
-187.89%
19.09
+162.55%
7.27
Average Dilution Earnings
—
0.00
-100.00%
0.63
-36.80%
1.00
Gain On Sale Of PPE
—
—
—
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
63.20
-31.25%
91.93
+4.88%
87.65
-1.84%
89.30
Current Assets
30.64
-35.62%
47.59
-21.78%
60.83
-0.79%
61.32
Cash Cash Equivalents And Short Term Investments
0.68
-85.68%
4.74
-72.84%
17.44
+1.01%
17.26
Cash And Cash Equivalents
0.68
-57.86%
1.61
-82.34%
9.11
+8.34%
8.41
Other Short Term Investments
0.00
-100.00%
3.13
-62.45%
8.33
-5.95%
8.86
Receivables
20.06
-43.99%
35.81
-3.35%
37.05
-1.73%
37.71
Accounts Receivable
34.90
-12.04%
39.68
+5.62%
37.57
+102.85%
18.52
Receivables Adjustments Allowances
-14.84
-284.14%
-3.86
-23.06%
-3.14
+19.51%
-3.90
Other Receivables
—
—
2.63
-88.63%
23.09
Inventory
1.14
-50.11%
2.29
-42.38%
3.98
-13.57%
4.60
Raw Materials
0.71
-33.61%
1.07
-68.29%
3.38
-24.98%
4.50
Work In Process
0.07
-45.38%
0.12
-84.22%
0.75
+190.00%
0.26
Finished Goods
0.38
-71.59%
1.32
+270.79%
0.36
+30.88%
0.27
Prepaid Assets
—
—
—
1.50
Restricted Cash
—
0.54
0.00
-100.00%
0.25
Assets Held For Sale Current
6.14
+120.26%
2.79
—
—
Other Current Assets
2.62
+33.76%
1.96
-17.37%
2.37
+58.16%
1.50
Total Non Current Assets
32.56
-26.56%
44.34
+65.36%
26.82
-4.16%
27.98
Net PPE
11.62
-22.05%
14.90
+31.33%
11.35
+9.64%
10.35
Gross PPE
20.60
-1.93%
21.00
+6.14%
19.79
+14.83%
17.23
Accumulated Depreciation
-8.98
-47.24%
-6.10
+27.74%
-8.44
-22.62%
-6.88
Properties
0.00
0.00
0.00
0.00
Land And Improvements
—
0.35
+0.00%
0.35
+0.00%
0.35
Buildings And Improvements
—
1.75
+0.98%
1.73
+0.00%
1.73
Machinery Furniture Equipment
3.43
+1.15%
3.39
-56.89%
7.86
+22.43%
6.42
Other Properties
15.93
-7.60%
17.24
+75.07%
9.85
+12.77%
8.73
Leases
1.24
+231.82%
0.37
0.00
—
Goodwill And Other Intangible Assets
14.98
-14.71%
17.56
+23.83%
14.18
-14.35%
16.56
Goodwill
5.23
+0.00%
5.23
-8.37%
5.71
+0.00%
5.71
Other Intangible Assets
9.75
-20.94%
12.33
+45.52%
8.47
-21.90%
10.85
Non Current Deferred Assets
0.00
-100.00%
7.31
0.00
—
Non Current Deferred Taxes Assets
0.00
-100.00%
7.31
0.00
—
Non Current Prepaid Assets
0.22
-73.92%
0.83
+587.60%
0.12
-73.70%
0.46
Other Non Current Assets
5.75
+54.09%
3.73
+220.81%
1.16
+91.28%
0.61
Total Liabilities Net Minority Interest
55.85
+31.27%
42.54
+77.14%
24.02
-21.68%
30.67
Current Liabilities
32.13
+54.07%
20.86
+29.75%
16.07
+3.55%
15.52
Payables And Accrued Expenses
17.94
+29.85%
13.81
+4.45%
13.22
+3.59%
12.77
Payables
15.70
+31.71%
11.92
+18.11%
10.10
+21.07%
8.34
Accounts Payable
13.72
+58.69%
8.64
+46.38%
5.91
-15.96%
7.03
Current Accrued Expenses
2.23
+18.14%
1.89
-39.58%
3.13
-29.33%
4.43
Pensionand Other Post Retirement Benefit Plans Current
0.06
-93.90%
1.03
+1966.00%
0.05
-16.67%
0.06
Total Tax Payable
1.99
-39.40%
3.28
-21.74%
4.19
+219.36%
1.31
Income Tax Payable
1.99
-39.40%
3.28
-21.74%
4.19
+219.36%
1.31
Current Debt And Capital Lease Obligation
6.57
+135.16%
2.79
+827.91%
0.30
-54.60%
0.66
Current Debt
3.21
—
—
—
Other Current Borrowings
3.21
—
—
—
Current Capital Lease Obligation
3.36
+20.34%
2.79
+827.91%
0.30
-54.60%
0.66
Current Deferred Liabilities
1.70
-28.72%
2.38
-4.68%
2.50
+22.86%
2.03
Current Deferred Revenue
1.70
-28.72%
2.38
-4.68%
2.50
+22.86%
2.03
Other Current Liabilities
5.87
+602.63%
0.83
—
—
Total Non Current Liabilities Net Minority Interest
23.71
+9.34%
21.69
+173.07%
7.94
-47.55%
15.14
Liabilities Heldfor Sale Non Current
2.92
+0.00%
2.92
—
—
Long Term Debt And Capital Lease Obligation
18.00
+14.95%
15.66
+135.22%
6.66
-53.23%
14.24
Long Term Debt
11.65
+58.88%
7.33
+205.58%
2.40
-76.10%
10.04
Long Term Capital Lease Obligation
6.35
-23.72%
8.33
+95.56%
4.26
+1.45%
4.20
Tradeand Other Payables Non Current
2.00
+0.00%
2.00
0.00
—
Non Current Deferred Liabilities
0.78
-28.73%
1.10
-14.26%
1.28
+41.77%
0.91
Non Current Deferred Revenue
0.78
-28.73%
1.10
+3.87%
1.06
+17.02%
0.91
Non Current Deferred Taxes Liabilities
—
0.00
-100.00%
0.22
0.00
Stockholders Equity
7.35
-85.11%
49.38
-22.39%
63.63
+8.53%
58.63
Common Stock Equity
7.35
-85.11%
49.38
-22.39%
63.63
+8.53%
58.63
Capital Stock
0.02
+27.78%
0.02
+12.50%
0.02
+0.00%
0.02
Common Stock
0.02
+27.78%
0.02
+12.50%
0.02
+0.00%
0.02
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
4.28
+15.76%
3.70
+7.71%
3.43
+6.29%
3.23
Ordinary Shares Number
2.99
+65.55%
1.80
+11.32%
1.62
+4.68%
1.55
Treasury Shares Number
1.29
-31.68%
1.89
+4.49%
1.81
+7.78%
1.68
Additional Paid In Capital
129.92
+9.46%
118.69
+8.76%
109.14
+4.39%
104.55
Retained Earnings
-58.39
-1061.13%
-5.03
-142.79%
11.75
+344.85%
2.64
Gains Losses Not Affecting Retained Earnings
-0.20
+34.00%
-0.30
-139.63%
0.76
+532.57%
-0.17
Treasury Stock
64.00
+0.00%
64.00
+10.28%
58.03
+19.89%
48.41
Other Equity Adjustments
-0.20
+34.00%
-0.30
-139.63%
0.76
+532.57%
-0.17
Total Equity Gross Minority Interest
7.35
-85.11%
49.38
-22.39%
63.63
+8.53%
58.63
Total Capitalization
19.00
-66.49%
56.72
-14.11%
66.03
-3.84%
68.67
Working Capital
-1.50
-105.60%
26.73
-40.28%
44.76
-2.26%
45.79
Invested Capital
22.21
-60.84%
56.72
-14.11%
66.03
-3.84%
68.67
Total Debt
24.57
+33.14%
18.46
+165.17%
6.96
-53.29%
14.90
Net Debt
14.18
+147.70%
5.72
—
1.63
Capital Lease Obligations
9.71
-12.66%
11.12
+143.90%
4.56
-6.19%
4.86
Net Tangible Assets
-7.63
-123.97%
31.82
-35.65%
49.45
+17.54%
42.07
Tangible Book Value
-7.63
-123.97%
31.82
-35.65%
49.45
+17.54%
42.07
Inventories Adjustments Allowances
-0.01
+96.35%
-0.22
+57.23%
-0.51
-17.70%
-0.43
Non Current Note Receivables
—
—
—
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-17.54
-47.53%
-11.89
-141.64%
28.55
+309.64%
-13.62
Cash Flow From Continuing Operating Activities
-11.80
+3.20%
-12.19
-142.71%
28.55
+309.64%
-13.62
Cash From Discontinued Operating Activities
-5.74
-1980.33%
0.30
—
—
Net Income From Continuing Operations
-49.52
-202.35%
-16.38
-188.72%
18.46
+194.32%
6.27
Depreciation Amortization Depletion
6.64
+2.67%
6.47
+27.86%
5.06
+42.04%
3.56
Depreciation
6.64
+2.67%
6.47
+27.86%
5.06
+42.04%
3.56
Depreciation And Amortization
6.64
+2.67%
6.47
+27.86%
5.06
+42.04%
3.56
Other Non Cash Items
1.49
+1025.00%
0.13
+3200.00%
0.00
+101.29%
-0.31
Stock Based Compensation
3.64
+2.88%
3.54
-11.29%
3.99
+25.23%
3.18
Provisionand Write Offof Assets
10.81
+1392.54%
0.72
+186.29%
-0.84
-120.30%
4.13
Asset Impairment Charge
0.00
-100.00%
0.09
-98.52%
6.16
+64.35%
3.75
Operating Gains Losses
0.26
+677.78%
-0.04
-119.82%
0.23
+37.58%
0.17
Gain Loss On Investment Securities
0.02
+181.82%
-0.02
-106.21%
0.35
+114.55%
0.17
Unrealized Gain Loss On Investment Securities
—
0.00
+100.00%
-0.17
-172.50%
0.24
Gain Loss On Sale Of PPE
-0.09
-295.65%
-0.02
—
0.00
Change In Working Capital
14.89
+321.50%
-6.72
-54.88%
-4.34
+87.46%
-34.62
Change In Receivables
4.74
+867.91%
-0.62
+86.28%
-4.50
+88.22%
-38.20
Changes In Account Receivables
4.74
+867.91%
-0.62
+86.28%
-4.50
+88.22%
-38.20
Change In Inventory
1.36
+700.00%
0.17
-75.78%
0.70
+140.21%
-1.75
Change In Prepaid Assets
-0.04
+79.17%
-0.22
+64.99%
-0.62
-142.70%
1.45
Change In Payables And Accrued Expense
3.62
+206.35%
1.18
+35.59%
0.87
-79.93%
4.34
Change In Accrued Expense
-0.16
+79.74%
-0.77
+13.09%
-0.89
-146.88%
1.89
Change In Payable
3.77
+93.44%
1.95
+11.04%
1.76
-28.29%
2.45
Change In Account Payable
5.07
+77.01%
2.86
+355.31%
-1.12
-145.76%
2.45
Change In Other Working Capital
6.15
+179.91%
-7.70
-1700.00%
0.48
-81.56%
2.61
Change In Other Current Assets
0.85
0.00
+100.00%
-0.56
-50.82%
-0.37
Change In Other Current Liabilities
-1.78
-491.45%
0.46
+162.98%
-0.72
+73.16%
-2.70
Investing Cash Flow
2.42
+276.92%
-1.37
+34.09%
-2.08
+89.44%
-19.67
Cash Flow From Continuing Investing Activities
2.70
+1005.03%
-0.30
+85.65%
-2.08
+89.44%
-19.67
Cash From Discontinued Investing Activities
-0.28
+74.32%
-1.07
—
—
Net PPE Purchase And Sale
0.23
+397.83%
0.05
-89.82%
0.45
0.00
Sale Of PPE
0.23
+397.83%
0.05
-89.82%
0.45
0.00
Capital Expenditure
-0.91
+56.53%
-2.08
+46.82%
-3.92
+7.37%
-4.23
Capital Expenditure Reported
-0.91
+56.53%
-2.08
+46.82%
-3.92
+7.37%
-4.23
Net Investment Purchase And Sale
3.37
-19.01%
4.17
+199.71%
1.39
+124.52%
-5.67
Purchase Of Investment
0.00
+100.00%
-3.82
+43.65%
-6.78
+68.52%
-21.53
Sale Of Investment
3.37
-57.75%
7.99
-2.23%
8.17
-48.50%
15.86
Net Business Purchase And Sale
0.00
+100.00%
-2.43
0.00
+100.00%
-9.07
Purchase Of Business
0.00
+100.00%
-2.90
0.00
+100.00%
-9.07
Net Other Investing Changes
—
0.48
—
-0.70
Financing Cash Flow
14.19
+146.40%
5.76
+122.12%
-26.02
-174.08%
35.13
Cash Flow From Continuing Financing Activities
13.21
+366.18%
2.83
+110.89%
-26.02
-174.08%
35.13
Net Issuance Payments Of Debt
5.61
-26.14%
7.60
+207.89%
-7.04
-15553.33%
-0.04
Issuance Of Debt
9.86
+29.76%
7.60
0.00
0.00
Repayment Of Debt
-4.25
0.00
+100.00%
-7.04
-15553.33%
-0.04
Long Term Debt Issuance
9.86
+29.76%
7.60
0.00
0.00
Long Term Debt Payments
-4.25
0.00
+100.00%
-7.04
-15553.33%
-0.04
Net Long Term Debt Issuance
5.61
-26.14%
7.60
+207.89%
-7.04
-15553.33%
-0.04
Net Common Stock Issuance
7.59
+227.27%
-5.97
+38.01%
-9.63
-124.24%
39.72
Common Stock Payments
0.00
+100.00%
-5.97
+38.01%
-9.63
-949.73%
-0.92
Common Stock Dividend Paid
—
0.00
+100.00%
-9.35
-105.74%
-4.55
Cash Dividends Paid
—
0.00
+100.00%
-9.35
-105.74%
-4.55
Repurchase Of Capital Stock
0.00
+100.00%
-5.97
+38.01%
-9.63
-949.73%
-0.92
Proceeds From Stock Option Exercised
0.00
-100.00%
1.20
0.00
—
Changes In Cash
-0.93
+87.59%
-7.50
-1762.97%
0.45
-75.52%
1.84
Beginning Cash Position
1.61
-82.34%
9.11
+5.21%
8.66
+27.02%
6.82
End Cash Position
0.68
-57.86%
1.61
-82.34%
9.11
+5.21%
8.66
Free Cash Flow
-18.44
-32.01%
-13.97
-156.72%
24.63
+237.99%
-17.85
Interest Paid Supplemental Data
3.10
+233.15%
0.93
+22.15%
0.76
-23.70%
1.00
Income Tax Paid Supplemental Data
1.13
-62.47%
3.00
+76.89%
1.70
0.00
Change In Income Tax Payable
-1.29
-41.82%
-0.91
-131.65%
2.88
—
Change In Tax Payable
-1.29
-41.82%
-0.91
-131.65%
2.88
—
Common Stock Issuance
7.59
0.00
0.00
-100.00%
40.63
Issuance Of Capital Stock
7.59
0.00
0.00
-100.00%
40.63
Sale Of Business
0.00
-100.00%
0.48
—
—
Cash From Discontinued Financing Activities
0.98
-66.55%
2.92
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category